SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-002120
Filing Date
2021-02-23
Accepted
2021-02-23 17:16:12
Documents
1
Period of Report
2021-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3276
  Complete submission text file 0001179110-21-002120.txt   4684
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053
Business Address
Lutz Robert Matthew (Reporting) CIK: 0001786203 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 21666797